Quick Takeaways
- FIRST MANHATTAN CO. LLC. filed SCHEDULE 13G/A for PAVmed Inc. Common Stock, Par Value $0.001 Per Share (PAVM).
- Disclosed ownership: 4.3%.
- Date of event: 31 Mar 2025.
FIRST MANHATTAN CO. LLC. - 31 Mar 2025 SCHEDULE 13G/A Report for PAVmed Inc. Common Stock, Par Value $0.001 Per Share (PAVM)
- Filing Manager
- FIRST MANHATTAN CO. LLC.
- Reporting Manager
- FIRST MANHATTAN CO. LLC.
- Symbol
- PAVM
- Shares outstanding
- 16,606,977 shares
- Disclosed Ownership
- 714,100 shares
- Ownership
- 4.3%
- Form type
- SCHEDULE 13G/A
- Filing time
- 15 May 2025, 13:14:39 UTC
- Date of event
- 31 Mar 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"FIRST MANHATTAN CO. LLC. disclosed 4.3% ownership in PAVmed Inc. Common Stock, Par Value $0.001 Per Share (PAVM) on 31 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 15 May 2025, 13:14.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| FIRST MANHATTAN CO. LLC. | 4.3% | 714,100 | 700,000 | 14,100 | Jeremy Covino | Chief Compliance Officer |